Psychopathology and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes

Aim. Continuous subcutaneous insulin infusion (CSII) is used as an option in patients with diabetes failing to multiple daily injections (MDI). Psychological factors may play a relevant role in the failure to attain therapeutic goals in patients on MDI. This could lead to an overrepresentation of ps...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotella, Francesco, Lamanna, Caterina, Dicembrini, Ilaria, Faravelli, Carlo, Calasso, Caterina, Mannucci, Edoardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793584/
https://www.ncbi.nlm.nih.gov/pubmed/24170982
http://dx.doi.org/10.1155/2013/672729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793584/
https://www.ncbi.nlm.nih.gov/pubmed/24170982
http://dx.doi.org/10.1155/2013/672729

Ejemplares similares